Quest Diagnostics reports third quarter 2026 financial results; raises revenue and EPS guidance for full year 2026

Summary

Third quarter revenues of $3.10 billion, up 10.0% from 2025, on strong organic revenue growth Third quarter reported diluted earnings per share ("EPS") of $2.78, up 28.7% from 2025; and adjusted diluting EPS of $3,00,...